上海昊海生物科技股份有限公司（股票代码：06826）于2026年6月2日发布截至2026年5月31日的股份变动月报。公告显示，公司本月注册股本未发生变动，合计仍为人民币229,980,895元。
根据报告，截至5月末，公司已发行H股为35,929,040股，A股为194,051,855股，合计较上月无增减变化。与此同时，公司此前于2025年6月10日购回的1,148,700股H股截至2026年5月31日仍未注销。期内，公司未新增发行股份或进行股份配售，也未有进一步的购回或其他股权激励计划变动。
报告显示，上述股份变动及购回安排均已获得公司董事会正式授权，并遵守香港联交所《上市规则》及相关法律法规的规定。公告由联席公司秘书田敏签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.